337520-16-8 Usage
Uses
Used in Pharmaceutical Industry:
t-Butyl 4-(2-bromo-4-nitrophenoxy)piperidine-1-carboxylate is used as a key intermediate in the synthesis of various pharmaceutical compounds. Its unique structure and functional groups enable the development of new drugs with potential therapeutic applications.
Used in Agrochemical Industry:
In the agrochemical industry, t-Butyl 4-(2-bromo-4-nitrophenoxy)piperidine-1-carboxylate serves as an essential building block for the creation of novel agrochemicals. Its incorporation into the molecular structure of these compounds can enhance their effectiveness in pest control and crop protection.
Used in Organic Synthesis:
t-Butyl 4-(2-bromo-4-nitrophenoxy)piperidine-1-carboxylate is utilized as a versatile intermediate in organic synthesis. Its reactivity and functional groups allow for the formation of a wide range of organic compounds, expanding the scope of chemical research and development.
Used in Research and Development:
t-Butyl 4-(2-bromo-4-nitrophenoxy)piperidine-1-carboxylate is also employed in research and development settings, where its unique properties and reactivity are explored for potential applications in various fields. Its use in the synthesis of new compounds and the study of their properties can contribute to advancements in chemistry and related disciplines.
Check Digit Verification of cas no
The CAS Registry Mumber 337520-16-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,3,7,5,2 and 0 respectively; the second part has 2 digits, 1 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 337520-16:
(8*3)+(7*3)+(6*7)+(5*5)+(4*2)+(3*0)+(2*1)+(1*6)=128
128 % 10 = 8
So 337520-16-8 is a valid CAS Registry Number.
337520-16-8Relevant articles and documents
BENZAMIDINE DERIVATIVES
-
, (2008/06/13)
Benzamidine derivatives of formula (I) or pharmaceutically acceptable salts thereof exhibit excellent inhibitory activity against factor Xa and are useful for treating or preventing blood coagulation disorders: wherein R 1represents a hydrogen atom, a halogen atom, an alkyl group or a hydroxyl group; R 2represents a hydrogen atom, a halogen atom or an alkyl group, R 3represents a hydrogen atom, an optionally substituted alkyl group, an aralkyl group, an optionally substituted alkanoyl group or an optionally substituted alkylsulfonyl group, R 4and R 5 are the same as or different from each other and each represent a hydrogen atom, a halogen atom, an optionally substituted alkyl group, an alkoxy group, a carboxyl group, an alkoxycarbonyl group or an optionally substituted carbamoyl group, and R 6represents a substituted pyrrolidine group or substituted piperidine group.